Form 4: Xtant Medical Holdings CEO Sean E. Browne Reports Stock Transaction
SEC Form 4 Filing
Sean E. Browne, President and CEO of Xtant Medical Holdings, reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On August 15, 2024, Sean E. Browne, the President and CEO of Xtant Medical Holdings, Inc., reported a transaction involving the disposition of 10,606 shares of common stock.
- The shares were withheld by the issuer to cover tax withholding obligations related to the vesting and settlement of restricted stock unit awards.
- Following the transaction, Browne beneficially owns 2,296,384 shares of Xtant Medical Holdings, Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions, and does not inherently convey positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is related to tax obligations of the CEO.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of stock transaction (disposition of shares). |
| 08/19/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.